The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,070.00
Bid: 3,088.00
Ask: 3,090.00
Change: 36.00 (1.19%)
Spread: 2.00 (0.065%)
Open: 3,046.00
High: 3,092.00
Low: 3,046.00
Prev. Close: 3,034.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Apr 2018 12:00

RNS Number : 4364K
Bunzl PLC
10 April 2018
 

Notification of transactions by person discharging managerial responsibilities

1

 

Details of the person discharging managerial responsibilities

a)

 

Name

 

 

Andrew Tedbury

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director UK & Ireland

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bunzl plc

b)

 

LEI

 

 

213800Q1Q9DV4L78UM09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 8,800 shares at £16.41 per share following the exercise of options granted in 2014 under Part A of the Long Term Incentive Plan (2014) and subsequent sale of 8,800 shares at £21.15 per share.

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

Volume(s)

£21.15

8,800

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2018-04-09

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 3,180 shares at nil cost following the exercise of awards granted in 2014 under Part B of the Long Term Incentive Plan (2014) and subsequent sale of 3,180 shares at £21.15 per share.

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

Volume(s)

£21.15

 

3,180

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2018-04-09

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 3

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 7,900 shares at £19.20 per share following the exercise of options granted in 2015 under Part A of the Long Term Incentive Plan (2014) and subsequent sale of 7,900 shares at £21.15 per share.

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

Volume(s)

£21.15

 

7,900

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2018-04-09

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 4

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 3,231 shares at nil cost following the exercise of awards granted in 2015 under the Bunzl Deferred Annual Share Bonus Scheme and subsequent sale of 3,231 shares at £21.15 per share.

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

Volume(s)

£21.15

 

3,231

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2018-04-09

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 5

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 2,420 shares at nil cost following the exercise of awards granted in 2015 under Part B of the Long Term Incentive Plan (2014) and subsequent sale of 2,420 shares at £21.15 per share.

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

Volume(s)

£21.15

 

2,420

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2018-04-09

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBBLFFVZFZBBL
Date   Source Headline
31st Aug 20217:00 amRNSAcquisition
4th Aug 202111:24 amRNSDirector/PDMR Shareholding
2nd Aug 20213:40 pmRNSTotal Voting Rights
14th Jul 20214:11 pmRNSDirector/PDMR Shareholding
7th Jul 20219:30 amRNSDirector/PDMR Shareholding
1st Jul 202112:30 pmRNSTotal Voting Rights
24th Jun 20217:00 amRNSTrading Statement
23rd Jun 20218:00 amRNSAdditional Listing
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20211:00 pmRNSTotal Voting Rights
26th May 20219:30 amRNSDirector Declaration
26th May 20218:00 amRNSAdditional Listing
18th May 20217:00 amRNSAcquisition
6th May 202110:40 amRNSDirector/PDMR Shareholding
5th May 20211:15 pmRNSDirector/PDMR Shareholding
5th May 20211:01 pmRNSDirector/PDMR Shareholding
4th May 202110:50 amRNSTotal Voting Rights
4th May 20219:25 amRNSBlock listing Interim Review
22nd Apr 20214:40 pmRNSDirector/PDMR Shareholding
21st Apr 20214:16 pmRNSResult of AGM
21st Apr 20217:00 amRNSTrading Statement
14th Apr 202111:45 amRNSDirector/PDMR Shareholding
12th Apr 20218:43 amRNSDirector/PDMR Shareholding
12th Apr 20218:24 amRNSDirector/PDMR Shareholding
7th Apr 20213:24 pmRNSDirector/PDMR Shareholding
1st Apr 202111:44 amRNSTotal Voting Rights
31st Mar 20215:34 pmRNSDirector/PDMR Shareholding
22nd Mar 20214:30 pmRNSDirector Declaration
17th Mar 20214:27 pmRNSAnnual Financial Report
8th Mar 20215:53 pmRNSDirector/PDMR Shareholding
5th Mar 20211:10 pmRNSDirector/PDMR Shareholding
4th Mar 20215:33 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector Declaration
1st Mar 20212:00 pmRNSTotal Voting Rights
1st Mar 20211:00 pmRNSDirector/PDMR Shareholding
1st Mar 20211:00 pmRNSDividend Declaration
1st Mar 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSAcquisition
1st Feb 202110:00 amRNSTotal Voting Rights
20th Jan 20217:00 amRNSDirector Declaration
6th Jan 20214:00 pmRNSDirector/PDMR Shareholding
4th Jan 202111:50 amRNSTotal Voting Rights
22nd Dec 20207:00 amRNSDirectorate Change
16th Dec 20208:00 amRNSAdditional Listing
16th Dec 20207:00 amRNSTrading Statement
9th Dec 20208:00 amRNSAdditional Listing
3rd Dec 20209:27 amRNSDirector/PDMR Shareholding
2nd Dec 20208:00 amRNSAdditional Listing
1st Dec 202011:57 amRNSTotal Voting Rights
20th Nov 202012:30 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.